A protest over a draft decision not to recommend a new cystic fibrosis drug is due later. Campaigners keen to see Kalydeco introduced across Wales are aiming to make their voices heard outside a meeting of the All Wales Medicines Strategy Group at the Angel Hotel in Abergavenny.
The group will look at the recommendation and decide whether to approve it or not. The drug - which is already available in England, Scotland and Northern Ireland - is the first licensed drug that treats the G551D mutation - the fundamental defect in those with cystic fibrosis.
More top news
A mild night with showers and dense misty patches!
Before the plane took off on February 16, teacher Juhel Miah was escorted off the flight by security.
Our Valleys Correspondent Hannah Thomas has been spending time discovering why the people who live in the Valleys love their communities.